Đặc điểm siêu âm nội soi viêm tụy mạn tại Trung tâm Tiêu hóa – Gan mật, Bệnh viện Bạch Mai giai đoạn 2024–2025

Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas leading to irreversible morphological damage, presenting a significant clinical challenge due to its insidious onset and severe complications, including an elevated risk of pancreatic cancer. The global incidence of CP highlights the critical need for accurate and early diagnostic tools to improve patient outcomes. Traditional diagnostic methods often struggle with detecting subtle changes in its early stages, where symptoms can be non-specific and overlap with other gastrointestinal disorders. Endoscopic ultrasound (EUS) has emerged as a superior imaging modality, offering high-resolution visualization of pancreatic parenchyma and ducts, thereby facilitating the identification of minute structural alterations. This study aims to characterize the specific findings of endoscopic ultrasound in patients with chronic pancreatitis at Bach Mai Hospital, utilizing the latest revised ECP-2019 criteria (2023 update) to enhance early diagnosis and staging.

Medical professionals, including gastroenterologists, hepatologists, radiologists, and internal medicine physicians, as well as researchers and academics specializing in pancreatic diseases and advanced diagnostic imaging.

This cross-sectional descriptive study aimed to delineate the characteristics of endoscopic ultrasound findings in patients diagnosed with chronic pancreatitis at the Gastroenterology and Hepatology Center, Bach Mai Hospital, between October 2024 and June 2025. Forty patients were enrolled, and their EUS images were meticulously analyzed according to the ECP-2019 modified 2023 criteria. Key findings revealed that the majority of patients were aged 40-60 years (60%), predominantly male (92.5%), with abdominal pain being the most prevalent symptom (95%). All patients (100%) exhibited pancreatic parenchymal lesions and hyperechoic strands on EUS, with hyperechoic foci present in 95% and parenchymal calcifications in 77.5%. Pancreatic cysts were noted in 55% of cases. Furthermore, 70% of patients presented with main pancreatic duct lesions, universally characterized by dilation. Crucially, the application of the ECP-2019 modified 2023 criteria significantly improved diagnostic accuracy, identifying chronic pancreatitis in 80% of cases previously suspected as per Rosemont 2007 criteria, thereby corresponding to early-stage chronic pancreatitis. This updated criterion proved highly effective not only in detecting the disease but also in stratifying its severity during nascent phases. The study underscores the enhanced capability of the revised ECP-2019 criteria in providing a more precise and detailed classification, offering significant clinical implications for improved patient management and prognostication for this challenging condition.